• Omega-3/6 fatty acids as adjuvants in the treatment of ADHD

    • 01/05/2018

    The cause of attention deficit hyperactivity disorder (ADHD) is complex and involves multiple factors, but it is thought that omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) play some sort of role. In line with this, there is clinical evidence to suggest that dietary supplementation with...

    Read more


  • Omega-3 LC-PUFA and reducing the risk of allergies

    • 01/12/2018

    When the hypothesis relating polyunsaturated fatty acids (PUFAs) to asthma was first proposed in the 1990s, opposite roles were attributed to omega-3 PUFA (reduction of inflammation) and omega-6 PUFA (mainly, arachidonic acid (AA), promotion of and inflammation). However, it has subsequently been...

    Read more


  • DHA and derived products can protect eye cells

    • 01/18/2018

    Preconditioning is the resilience of a cell, tissue or organ to a lethal stimulus, previously acquired protection due to exposure to a sub-lethal stimulus. Docosahexaenoic acid (DHA) and derived products, the docosanoids 17-hydroxy DHA (17-DHA) and neuroprotectin D1 (NPD1), synthesised by 15-...

    Read more


  • Fish oil supplementation and surgery

    • 01/24/2018

    Ever since Dyerberg et al. showed that the bleeding time among Greenland Inuit was longer than among the Danish and found that platelets in the Inuit had a high concentration of omega-3 polyunsaturated fatty acids (PUFA), the impact of n-3 PUFAs on haemostasis has been the subject of debate....

    Read more